Literature DB >> 33172656

Amoxicillin-clavulanic acid-induced type II Kounis syndrome during general anaesthesia complicated with hypoxic-ischaemic encephalopathy.

J M Peláez-Pérez1, M Sánchez Casado2, I Álvarez-Twose2, N G Kounis3.   

Abstract

Anaphylaxis is a severe acute multisystem syndrome involving massive mediator release from mast cells and basophils. Although the entire arterial system can be affected, when coronary arteries are the main targets, Kounis syndrome needs to be considered. Cerebral artery involvement has also been suggested in rarer MC-mediator release episodes; so-called 'Kounis-like' syndrome. Cerebral ischaemic lesions can then result from low blood pressure or direct proinflammatory and/or vasoconstrictive mediator action in the cerebral arterial system. Diagnosis can be difficult in anaesthetised patients, as low blood pressure can have multiple causes. Treatment is also challenging, as administering adrenaline can worsen ischaemia. We report the first case of amoxicillin-clavulanic acid-induced type II Kounis syndrome under general anaesthesia, complicated with severe, irreversible and subsequently fatal encephalopathy of ischaemic origin. This case can contribute to awareness of less common Kounis syndrome manifestations, including severe cerebral involvement, or other anaphylactic reactions with atypical presentations.
Copyright © 2020 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Adrenalina; Adrenaline; Anaesthesia; Anafilaxia; Anaphylaxis; Anestesia; Brain injury; Kounis syndrome; Lesión cerebral; Síndrome de Kounis

Year:  2020        PMID: 33172656     DOI: 10.1016/j.redar.2019.06.009

Source DB:  PubMed          Journal:  Rev Esp Anestesiol Reanim (Engl Ed)        ISSN: 2341-1929


  2 in total

Review 1.  Kounis syndrome: from an unexpected case in the Emergency Room to a review of the literature.

Authors:  Erika Poggiali; Irene Benedetti; Valeria Vertemati; Luca Rossi; Alberto Monello; Manuela Giovini; Andrea Magnacavallo; Andrea Vercelli
Journal:  Acta Biomed       Date:  2022-03-14

2.  Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity.

Authors:  Alberto Navarro-Navajas; Ingrid Casallas; Daniel Isaza; Paola Ortiz; Daniela Baracaldo-Santamaría; Carlos-Alberto Calderon-Ospina
Journal:  Medicina (Kaunas)       Date:  2022-06-26       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.